Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.4680
+0.1904 (68.59%)
Jun 4, 2025, 1:50 PM - Market open
Cellectar Biosciences Market Cap
Cellectar Biosciences has a market cap or net worth of $21.57 million as of June 4, 2025. Its market cap has decreased by -81.94% in one year.
Market Cap
21.57M
Enterprise Value
-639.05K
1-Year Change
-81.94%
Ranking
Category
Stock Price
$0.47
Market Cap Chart
Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $21.57M, an increase of 187.54%. That is a compound annual growth rate of 5.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2025 | 12.80M | 4.07% |
| Dec 31, 2024 | 12.30M | -63.82% |
| Dec 29, 2023 | 34.00M | 112.50% |
| Dec 30, 2022 | 16.00M | -60.59% |
| Dec 31, 2021 | 40.60M | -27.24% |
| Dec 31, 2020 | 55.80M | 164.45% |
| Dec 31, 2019 | 21.10M | 185.14% |
| Dec 31, 2018 | 7.40M | -65.90% |
| Dec 29, 2017 | 21.70M | 233.85% |
| Dec 30, 2016 | 6.50M | 3.17% |
| Dec 31, 2015 | 6.30M | -73.08% |
| Dec 31, 2014 | 23.40M | 10.38% |
| Dec 31, 2013 | 21.20M | -38.19% |
| Dec 31, 2012 | 34.30M | 190.68% |
| Dec 30, 2011 | 11.80M | 247.06% |
| Dec 31, 2010 | 3.40M | -97.92% |
| Dec 31, 2009 | 163.20M | 1,484.47% |
| Dec 31, 2008 | 10.30M | -56.90% |
| Dec 31, 2007 | 23.90M | -22.90% |
| Dec 29, 2006 | 31.00M | -30.49% |
| Dec 30, 2005 | 44.60M | 494.67% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.87B |
| Johnson & Johnson | 371.26B |
| AbbVie | 330.11B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 272.50B |
| Abbott Laboratories | 230.89B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |